GKB Ophthalmics Current Share Price | GKB Ophthalmics Stock Screener
GKB
Medical Equipment
GKB Ophthalmics Current Stock Price Today
Live Share Price NSE
₹60.90
▼
-2.13 (-3.38%)
Live Share Price BSE
₹63.95
▲
0.27 (0.42%)
As of August 19, 2026, the live GKB Ophthalmics share price (NSE: GKB) is ₹60.90 on NSE and ₹63.95 on BSE, down 3.38% from the previous close, with shares trading between ₹60.50 and ₹64.50 in today's trading session, and a 52-week range of ₹60.90–₹65.00.
Analyse GKB price trends and track historical price performance.
Use the GKB Ophthalmics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
GKB Ophthalmics Market Cap
₹32.76 Cr.
GKB P/E Ratio (TTM)
5.94
GKB Ophthalmics P/B Ratio
0.62
EPS (TTM)
₹-7.08
Dividend Yield
-
Debt to Equity
0.25
GKB 52 Week High
₹65.00
GKB Ophthalmics 52 Week Low
₹60.90
Operating Margin
8.00%
Profit Margin
5.88%
GKB Revenue (TTM)
₹34.00
EBITDA
₹3.00
Net Income
₹2.00
Total Assets
₹132.00
Total Equity
₹55.00
GKB Ophthalmics Current Share Price Chart
Track the current GKB Ophthalmics share price and stock price with an interactive chart. Analyse GKB price trends, trading volume, historical performance, and volatility across different timeframes — the complete GKB Ophthalmics stock quote in one place.
GKB Ophthalmics Company Profile - Fundamental Screener
Screen GKB Ophthalmics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GKB shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE265D01015
GKB Ophthalmics Balance Sheet Screener
Screen GKB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 132 | 125 | 115 | 112 | 110 | 107 | 102 | 93 | 83 | 82 |
| Current Assets | 108 | 99 | 88 | 84 | 76 | 74 | 73 | 64 | 64 | 63 |
| Fixed Assets | 15 | 17 | 18 | 19 | 23 | 24 | 26 | 26 | 18 | 18 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 6 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 55 | 56 | 64 | 67 | 67 | 66 | 59 | 55 | 45 | 47 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Reserves & Surplus | 48 | 47 | 55 | 58 | 58 | 58 | 54 | 47 | 41 | 43 |
GKB Ophthalmics Income Statement Screener - Profit & Revenue Analysis
Screen GKB Ophthalmics income statement and profit fundamentals.
Analyze GKB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for GKB Ophthalmics share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 31 | 58 | 31 | 33 | 31 | 26 | 26 | 26 | 22 | 24 | 21 | 23 | 20 | 19 |
| Expenses | 30 | 28 | 55 | 27 | 32 | 34 | 27 | 26 | 25 | 22 | 25 | 21 | 21 | 20 | 19 |
| EBITDA | 3 | 2 | 2 | 3 | 1 | -3 | -1 | 0 | 1 | 1 | 0 | 0 | 2 | 0 | 0 |
| Operating Profit % | 8.00% | 5.00% | 2.00% | 10.00% | 2.00% | -9.00% | -4.00% | 0.00% | 4.00% | 0.00% | -3.00% | -1.00% | 6.00% | -2.00% | 0.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 1 | 1 | 2 | -1 | -4 | -2 | -1 | 0 | -1 | -1 | -1 | 1 | -2 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 1 | 1 | 2 | -1 | -4 | -2 | -1 | 0 | -1 | -1 | -1 | 1 | -2 | -1 |
| EPS | 2.00 | 0.38 | 0.08 | 3.17 | -2.02 | -7.03 | -4.03 | -2.41 | -0.50 | -1.81 | -2.48 | -2.32 | 1.04 | -3.80 | -2.05 |
GKB Ophthalmics Cash Flow Screener - Liquidity Fundamentals
Screen GKB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -4 | -3 | 4 | -3 | 5 | 7 | 3 | 4 | -3 | -3 |
| Investing Activities | 9 | 3 | -2 | 1 | -4 | -17 | -4 | -10 | 1 | 4 |
| Financing Activities | -6 | 1 | -2 | -2 | -2 | 3 | 4 | 13 | 1 | -1 |
| Net Cash Flow | 0 | 0 | 1 | -4 | 0 | -7 | 4 | 7 | 0 | -1 |
GKB Ophthalmics Shareholding Pattern Screener
See GKB Ophthalmics shareholding pattern with promoter, FII, and DII holdings.
Check GKB Ophthalmics promoter holding and ownership changes for GKB on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.13% | 51.15% | 50.99% | 51.06% | 51.06% | 51.13% | 50.93% | 50.95% |
| FII Holding | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.52% | 38.97% | 37.36% | 37.22% | 37.23% | 38.55% | 36.04% | 36.64% |
| Other Holding | 8.57% | 8.09% | 9.87% | 9.94% | 9.93% | 8.53% | 11.23% | 10.63% |
| Shareholder Count | 2,634 | 2,557 | 2,538 | 2,550 | 2,601 | 2,661 | 2,370 | 2,690 |
GKB Ophthalmics Share Dividend Screener - Share Yield Analysis
Check GKB Ophthalmics dividend history with payout and yield data.
View GKB Ophthalmics dividend details including ex-dates and amounts for GKB stock.
GKB Ophthalmics Stock Index Membership
See which indices include GKB Ophthalmics stock.
Check GKB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
GKB Ophthalmics Market Events Screener - Corporate Actions
Get GKB Ophthalmics corporate actions including splits, bonuses, and buybacks.
Check GKB Ophthalmics stock events that may affect GKB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-25 | 2026-08-25 | Annual General Meeting | NA | 17.05% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 4.35% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | -0.93% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 0.63% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -11.47% |
| 2025-08-21 | 2025-08-21 | Annual General Meeting | NA | 9.47% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.78% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 4.58% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -1.18% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.14% |
| 2024-08-20 | 2024-08-20 | Annual General Meeting | NA | 24.77% |
GKB Ophthalmics Competitors Screener - Peer Comparison
Screen GKB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 17,572 | 57.93 | 1,875 | 6.61% | 326 | 51.74 |
| Tarsons Products | 1,923 | 174.21 | 423 | 3.45% | 16 | 69.69 |
| Q-Line Biotech | 1,234 | 22.30 | 342 | 5.93% | 56 | 49.64 |
| Laxmi Dental | 1,103 | 36.06 | 272 | 12.00% | 22 | 34.34 |
| Vasa Denticity | 711 | 62.52 | 279 | 10.97% | 10 | 53.41 |
| Osel Devices | 667 | 24.00 | 293 | 56.84% | 30 | 34.92 |
| Fabtech Technologies | 649 | 13.49 | 411 | 22.29% | 36 | 37.27 |
| Hemant Surgical Industries | 518 | 29.18 | 232 | 107.34% | 19 | 41.96 |
| Prevest Denpro | 461 | 21.09 | 72 | 7.02% | 21 | 48.51 |
| Nureca | 325 | 76.82 | 155 | 27.03% | 2 | 62.66 |
GKB Ophthalmics Company Announcements - News Screener
Screen GKB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Ltd. Held On August 12 2026 | - |
| 2026-08-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Disclosure Of Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015("Listing Regulations) | - |
| 2026-07-31 | Notice For Book Closure | - |
| 2026-07-31 | Reg. 34 (1) Annual Report. | - |
| 2026-07-25 | Board Meeting Intimation for Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-14 | Disclosure Of Information Pursuant To Regulation 30- Update On Case No. 32/09 Filed For Adjudication Of Charter Of Demands | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-27 | Board Meeting Outcome for GKB_Outcome Of The Board Meeting Held On May 27 2026 | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-05-23 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-04 | Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ende March 31 2026. | - |
| 2026-04-07 | Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018 | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |